Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2018, Vol. 12 ›› Issue (03): 181-184. doi: 10.3877/cma.j.issn.1674-0785.2018.03.013

Special Issue:

• Review • Previous Articles     Next Articles

Application and prospect of CT-guided 125I radioactive particle implantation in treatment of unresectable pancreatic cancer

Weixia Wu1, Zhigang Zhou1,(), Mingquan Xing2   

  1. 1. Radiology Department, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
    2. Changzhi Medical College, Changzhi 046000, China
  • Received:2017-09-10 Online:2018-02-01 Published:2018-02-01
  • Contact: Zhigang Zhou
  • About author:
    Corresponding author: Zhou Zhigang, Email:

Abstract:

In recent years, 125I radioactive particle implantation has significantly improved the survival rate and quality of life in patients with unresectable pancreatic cancer, because it can effectively control tumor growth, relieve the pain of patients, and prolong the survival time of the patients. The clinical research of CT-guided 125I radioactive particle implantation for the treatment of unresectable pancreatic cancer has greatly increased, and the application of 3D printing template-based individualized treatment planning system has become a hot topic, although particle dose selection is still a challenge. In this paper, we review the progress of CT-guided 125I radioactive particle implantation in the treatment of unresectable pancreatic cancer, with an aim to promote its future clinical application.

Key words: Pancreatic cancer, 125I radioactive particle, Dosimetry

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd